Lung metastases are a serious and often advanced stage of cancer, indicating that the disease has spread from its primary site to the lungs. While this diagnosis can be overwhelming, there are ...

Moleculin Biotech has announced encouraging topline efficacy outcomes from its US Phase IB/II trial, MB-107, of Annamycin for soft tissue sarcoma lung metastases (STS lung mets) treatment.

Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

That’s where lung metastases are usually found. Scientists sometimes refer to it as the seed-and-soil hypothesis, the tumor being the seed and the soil being the organ receptive to that seed.

Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases. Additionally, the Company is ...

The clinical benefit rate was 59.4%, with one participant achieving a partial response and 18 showing stable disease.

announced positive results from its U.S. Phase 1B/2 clinical trial of Annamycin for treating soft tissue sarcoma lung metastases (STS lung mets). According to InvestingPro data, while the company ...

Additionally, the improvement seen with PFS after two doses represents a real potential for Annamycin to provide a meaningful treatment option for the treatment of STS lung mets,” commented Walter ...

Additionally, the improvement seen with PFS after two doses represents a real potential for Annamycin to provide a meaningful treatment option for the treatment of STS lung mets,” commented ...